Filing Details
- Accession Number:
- 0000899243-23-002219
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-19 19:57:34
- Reporting Period:
- 2023-01-17
- Accepted Time:
- 2023-01-19 19:57:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1157601 | Madrigal Pharmaceuticals Inc. | MDGL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1454983 | S Richard Levy | C/O Madigral Pharmaceuticals, Inc. 200 Barr Harbor Drive, Suite 200 West Conshohocken PA 19428 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-01-17 | 12,489 | $105.08 | 21,589 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-01-17 | 10,000 | $100.45 | 31,589 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-01-17 | 100 | $285.28 | 31,489 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-01-17 | 400 | $287.08 | 31,089 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-01-17 | 300 | $288.91 | 30,789 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-01-17 | 1,600 | $290.36 | 29,189 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-01-17 | 3,325 | $291.66 | 25,864 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-01-17 | 5,227 | $292.68 | 20,637 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-01-17 | 3,548 | $293.54 | 17,089 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-01-17 | 5,164 | $294.68 | 11,925 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-01-17 | 2,325 | $295.45 | 9,600 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-01-17 | 500 | $296.68 | 9,100 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to buy) | Disposition | 2023-01-17 | 12,489 | $0.00 | 12,489 | $105.08 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-01-17 | 10,000 | $0.00 | 10,000 | $100.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-06-17 | No | 4 | M | Direct | |
| 0 | 2024-06-27 | No | 4 | M | Direct |
Footnotes
- All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. After giving effect to these transactions, the reporting person's Rule 10b5-1 trading plan has been concluded and no more trading will be conducted thereunder.
- All shares issued pursuant to the exercise of these options represent 12,489 shares underlying an option award of 12,489 shares. All exercised options vested June 17, 2022.
- All shares issued pursuant to the exercise of these options represent 10,000 shares underlying an option award of 10,000 shares. All exercised options vested June 27, 2020.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $286.99 to $287.16, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $288.73 to $289.01, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $289.80 to $290.79, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $291.08 to $292.07, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $292.11 to $293.09, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $293.12 to $294.11, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $294.17 to $295.16, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $295.26 to $296.15, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $296.43 to $296.77, inclusive.
Billionaire Hedge Funds
